Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
| 1.38 | |
| 1.48 | |
| - | |
| 1.545 | |
| 1.21 | |
| 0.894-5.94 | |
| 7 671 K | |
| 4 102 K | |
| 1 960 K | |
| -1.0384 | |
| 1.156 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Artificial intelligence and penny stocks don’t necessarily go together like peanut butter and jelly, but there is some allure to AI penny stocks for risk-tolerant investors. In 2023, companies were...
PITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, exte...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
